Skip to main content
  • Advertise
    Want to Advertise with Us?
    Conquer welcomes advertising and sponsorship collaborations with reputable companies offering high-quality products and services to people affected by cancer.
  • Affiliated Brands
    Academy of Oncology Nurse & Patient Navigators
    The Academy of Oncology Nurse & Patient Navigators (AONN+) is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. Our organization of over 8,900 members was founded in May 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services to better manage the complexities of the cancer care treatment continuum for their patients. We view our organization as one consisting of “professional patient advocates” and, to that end, we support and serve our members.
    Journal of Oncology Navigation & Survivorship
    The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
    The Oncology Nurse-APN/PA
    The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
  • Healthcare Providers
  • Contribute

Genetics and Genomics

Molecular Profiling and Immunotherapy Offered Me New Hope After Stage IV Lung Cancer Diagnosis
Christie Bevington shares her story of how immunotherapy was the only treatment that helped stop her cancer progression and relieve her back pain caused by lung cancer. Read More ›

Molecular Profiling Is Making Cancer Treatment Personal
Tim Dorius, MD, explains the role of molecular profiling in relation to immunotherapy, and how oncologists can now look at the genetic makeup of a tumor to identify specific mutations or other biomarkers. Read More ›

Genetic Predisposition to Breast Cancer: Moving from “Why Me?” to “What’s Next?”

Learning I Had Lynch Syndrome Helped Save My Life
Lynch syndrome is a hereditary genetic abnormality that can cause several types of cancer. Wenora Johnson discovered that it ran in her family after she had treatment for colon cancer. Knowing that she was at a high risk for certain cancers, and having 2 children already, she had her ovaries and uterus removed, as prevention. Read More ›

Genetic, Genomic, or Biomarker Testing in Cancer—What Is the Difference?
Genetic testing, genomic testing, molecular profiling—how can you make sense of these terms to ensure you receive the best test and best treatment in this era of targeted therapies? A group of experts and patient advocates provide answers to these questions. Read More ›

Biomarker Testing Crucial for Patients with Cholangiocarcinoma
New treatments are becoming available for patients with cholangiocarcinoma (bile duct cancer). Testing for specific biomarkers is crucial to ensure each patient receives the best available treatment for any associated biomarker. Read More ›

Biomarkers in Lung Cancer: What Are They and Why Do They Matter?
Patients with advanced lung cancer should be tested for the 5 most common biomarkers so they may receive the best treatment options for their disease. Read More ›

Using My Lung Cancer Story to Advocate for Change in Minority Communities
After getting tested for genetic abnormalities, Brandi Bryant learned she had the ALK genetic mutation, which increases the risk for lung cancer. This information resulted in important changes in her treatment and led her to become an advocate for genetic testing, especially among minority communities. Read More ›

The CDH1 Gene Mutation:  My Family’s Story of  Hereditary Cancer
Jon Grossman shares his powerful story of learning he inherited the genetic mutation that caused his mother’s stomach cancer, and the drastic steps he took to ensure he will not have that cancer. Read More ›

Patients' Roadmap to Genetic Counseling and Testing: What Should You Expect?
Genetics play an important role in cancer treatments today. Working with genetic counselors helps to determine if a patient’s cancer has a genetic component, which will influence treatment decisions. Genetic counselor Megan Mortenson explains how genetic counseling may help you or your loved one. Read More ›

Page 2 of 4